Unit
- Device classification: Regulatory bodies like the FDA and EU MDR categorize devices by risk. Class I devices present minimal risk (e.g., tongue depressors), Class II require special controls (e.g., infusion pumps), and Class III support or sustain human life (e.g., pacemakers). Classification determines the rigor of the approval pathway.
- Product lifecycle stages: The typical lifecycle includes concept, design and development, verification and validation, manufacturing, post-market surveillance, and eventual retirement. Each stage has distinct documentation and review requirements under design control regulations.
- Regulatory bodies and standards: The FDA 21 CFR Part 820 and ISO 13485 govern design controls internationally. The Medical Device Regulation (MDR) in Europe adds clinical evaluation and unique device identification (UDI) requirements. Understanding which regulations apply is the first step in any project.
- Role of design history file: A DHF contains all design records, from user needs to final specifications. It demonstrates traceability and is audited during regulatory submissions. Maintaining an accurate DHF is a legal obligation for manufacturers.
- Design control process overview: Design controls are a systematic set of practices ensuring that devices meet user needs and intended uses. They include design planning, input, output, review, verification, validation, and transfer. These controls reduce the risk of recalls and design flaws.
- Stakeholder identification: Medical device design involves clinicians, patients, hospital administrators, regulatory experts, and manufacturers. Each stakeholder group has unique needs; for example, clinicians prioritize ease of use, while regulators focus on safety data.
- Usability engineering integration: IEC 62366 specifies a usability engineering process to minimize use errors. It involves understanding users, use environments, and tasks. Formative studies during design reduce risks before final validation.
- Post-market surveillance: After launch, manufacturers must monitor device performance through complaint handling, adverse event reporting, and periodic safety updates. This data feeds back into design improvements for next-generation products.
- Risk management alignment: ISO 14971 requires risk management throughout the device lifecycle. Design teams identify hazards, estimate risks, and implement controls. Risk analysis documents are cross-referenced in the DHF and submitted with regulatory applications to demonstrate safety.
- Design transfer to manufacturing: Design transfer ensures that the final design can be produced consistently at scale. It includes specifications, work instructions, and quality assurance steps. Incomplete transfer can lead to production errors and nonconformities, making it a critical control point.
- Clinical evaluation planning: For higher risk devices, clinical evaluation under MEDDEV 2.7/1 Rev.4 or MDR Annex XIV is required. It involves literature reviews, clinical investigations, or both. Planning early avoids delays in regulatory submissions and ensures sufficient evidence of safety and performance.
Design Principle
Principle: Layered Risk Classification
Definition: Medical devices are stratified into risk classes that dictate the depth of design control required. Each class imposes specific requirements for clinical evidence, manufacturing controls, and post-market vigilance.
Application: At project initiation, map the intended device to the appropriate class by consulting the FDA classification database or EU MDR annexes. For example, a Class II device like a blood pressure monitor needs 510(k) clearance with substantial equivalence to a predicate device, while a Class III device requires premarket approval (PMA) with clinical trial data. Design teams should allocate resources proportionally: high-risk devices demand more rigorous testing and documentation early in development.
Quick Revision
- Device classification (I, II, III) determines regulatory pathway and design control depth.
- The design history file is a living document that traces all design decisions.
- Design controls are mandatory under 21 CFR Part 820 and ISO 13485.
- Usability engineering per IEC 62366 is integrated early to prevent use errors.
- Post-market surveillance closes the loop for continuous improvement.